Cutting edge: Engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset

被引:79
作者
Barakonyi, A
Rabot, M
Marie-Cardine, A
Aguerre-Girr, M
Polgar, B
Schiavon, V
Bensussan, A
Le Bouteiller, P
机构
[1] Fac Med Creteil, INSERM U448, F-94010 Creteil, France
[2] Hop Purpan, INSERM U563, Ctr Physiopathol Toulouse Purpan, F-31024 Toulouse 3, France
关键词
D O I
10.4049/jimmunol.173.9.5349
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD160 is an Ig-like activating NK cell receptor expressed on the majority of circulating NK cells. This population corresponds to the nonproliferating, highly cytolytic, CD57(dim) CD16(+) subset. CD160 engagement by HLA-C molecules mediates cytotoxic function. In this study, we report that upon specific activation by the physiological ligand HLA-C, or A cross-linking, CD160(+) peripheral blood NK cells produce IFN-gamma, TNF-alpha, and IL-6 This unique CD160-mediated cytokine production differs from the one observed after CD16 engagement whose expression is also restricted to the CD56(dim) cytotoxic NK cell subset. As already reported for the CD160-mediated cytotoxic effector function, CD160-mediated cytokine production by peripheral blood-NK cells is negatively controlled by the killer Ig-like receptor CD158b. Thus, the CD160 receptor represents a unique triggering surface molecule expressed by cytotoxic NK cells that participates in the inflammatory response and determines the type of subsequent specific immunity.
引用
收藏
页码:5349 / 5354
页数:6
相关论文
共 19 条
  • [1] Agrawal S, 1999, J IMMUNOL, V162, P1223
  • [2] Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
    André, P
    Castriconi, R
    Espéli, M
    Anfossi, N
    Juarez, T
    Hue, S
    Conway, H
    Romagné, F
    Dondero, A
    Nanni, M
    Caillat-Zucman, S
    Raulet, DH
    Bottino, C
    Vivier, E
    Moretta, A
    Paul, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) : 961 - 971
  • [3] Anumanthan A, 1998, J IMMUNOL, V161, P2780
  • [4] Recognition of infected cells by natural killer cells
    Carayannopoulos, LN
    Yokoyama, WM
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) : 26 - 33
  • [5] Natural killer cells, viruses and cancer
    Cerwenka, A
    Lanier, LL
    [J]. NATURE REVIEWS IMMUNOLOGY, 2001, 1 (01) : 41 - 49
  • [6] Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry, allergies vs. non-allergies
    Cook, EB
    Stahl, JL
    Lowe, L
    Chen, R
    Morgan, E
    Wilson, J
    Varro, R
    Chan, A
    Graziano, FM
    Barney, NP
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 254 (1-2) : 109 - 118
  • [7] The biology of human natural killer-cell subsets
    Cooper, MA
    Fehniger, TA
    Caligiuri, MA
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (11) : 633 - 640
  • [8] NK cell compartments and their activation by dendritic cells
    Ferlazzo, G
    Münz, C
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (03) : 1333 - 1339
  • [9] The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
    Ferlazzo, G
    Thomas, D
    Lin, SL
    Goodman, K
    Morandi, B
    Muller, WA
    Moretta, A
    Münz, C
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (03) : 1455 - 1462
  • [10] Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity
    Hsiao, YW
    Liao, KW
    Hung, SW
    Chu, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (03) : 1508 - 1514